Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab
Journal
-
- Allergy, Asthma & Clinical Immunology
-
Allergy, Asthma & Clinical Immunology 10 (1), 7-, 2014-02-27
Springer Science and Business Media LLC
- Tweet
Details 詳細情報について
-
- CRID
- 1361699995512085504
-
- ISSN
- 17101492
-
- Data Source
-
- Crossref